DMAC vs MPWR · $157.4M cap vs P/E 112, rev $2.21B
DiaMedica Therapeutics Inc (DMAC) versus Monolithic Power Systems Inc (MPWR) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Monolithic Power Systems Inc (MPWR) is a semiconductors company listed on US.
DMAC does not have a complete income-statement cache yet.
Latest reported MPWR revenue for 2024-12-31 was $2.21B. Net income was $1.79B. Revenue was up 21.2% from 2023-12-31 to 2024-12-31. MPWR currently screens at market cap $77.49B and trailing P/E 112.3.
DMAC currently screens at market cap $157.4M. MPWR currently screens at market cap $77.49B and trailing P/E 112.3.
Not investment advice. Open the DMAC and MPWR stock pages for the full models.
Not investment advice.